• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Minimum expectations for market authorization of continuous glucose monitoring devices in Europe-'eCGM' compliance status.

作者信息

Mathieu Chantal, Irace Concetta, Wilmot Emma G, Akra Bassil, Del Prato Stefano, Cuesta Martin, Adolfsson Peter, Klupa Tomasz, Renard Eric, Battelino Tadej

机构信息

Department of Endocrinology, University Hospitals Leuven, Leuven, Belgium.

Department of Health Science, University Magna Græcia, Catanzaro, Italy.

出版信息

Diabetes Obes Metab. 2025 Mar;27(3):1025-1031. doi: 10.1111/dom.16153. Epub 2024 Dec 26.

DOI:10.1111/dom.16153
PMID:39726200
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11802390/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff7e/11802390/1d9a8621aeee/DOM-27-1025-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff7e/11802390/1d9a8621aeee/DOM-27-1025-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff7e/11802390/1d9a8621aeee/DOM-27-1025-g001.jpg

相似文献

1
Minimum expectations for market authorization of continuous glucose monitoring devices in Europe-'eCGM' compliance status.欧洲连续血糖监测设备市场授权的最低期望——“eCGM”合规状态
Diabetes Obes Metab. 2025 Mar;27(3):1025-1031. doi: 10.1111/dom.16153. Epub 2024 Dec 26.
2
CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review.连续血糖监测（CGM）准确性：对比欧洲合格认证（CE）标志与美国（食品药品监督管理局，FDA）和澳大利亚（治疗用品管理局，TGA）的政府监管：一项叙述性综述。
Diabetes Obes Metab. 2023 Apr;25(4):916-939. doi: 10.1111/dom.14962. Epub 2023 Feb 5.
3
Comparison of bench test results measuring the accuracy of peak flow meters.比较测量峰值流量计准确性的台架测试结果。
BMC Pulm Med. 2019 Apr 8;19(1):74. doi: 10.1186/s12890-019-0837-3.
4
Gaps in the evidence underpinning high-risk medical devices in Europe at market entry, and potential solutions.高风险医疗器械在进入欧洲市场时的证据基础存在差距，以及潜在的解决方案。
Orphanet J Rare Dis. 2023 Jul 25;18(1):212. doi: 10.1186/s13023-023-02801-7.
5
[Requirements for CE-marking of apps and wearables].[应用程序和可穿戴设备的CE认证要求]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Mar;61(3):314-320. doi: 10.1007/s00103-018-2694-2.
6
Pendra goes Dutch: lessons for the CE mark in Europe.彭德拉采用各自付费的方式：欧洲CE标志的教训。
Diabetologia. 2005 Jun;48(6):1055-8. doi: 10.1007/s00125-005-1754-y. Epub 2005 May 4.
7
Considerations for an institution for evaluation of diabetes technology devices to improve their quality in the European Union.关于在欧盟设立糖尿病技术设备评估机构以提高其质量的考量。
J Diabetes Sci Technol. 2013 Mar 1;7(2):542-7. doi: 10.1177/193229681300700230.
8
["Medical devices and European regulations"].["医疗器械与欧洲法规"]
Ann Pharm Fr. 1997;55(2):73-6.
9
The IVD directive: planning for compliance.体外诊断医疗器械指令：合规规划。
Med Device Technol. 2002 May;13(4):22-4.
10
Contrasting clinical evidence for market authorisation of cardio-vascular devices in Europe and the USA: a systematic analysis of 10 devices based on Austrian pre-reimbursement assessments.欧洲和美国心血管设备市场授权的对比临床证据：基于奥地利预报销评估对10种设备的系统分析
BMC Cardiovasc Disord. 2014 Nov 4;14:154. doi: 10.1186/1471-2261-14-154.

引用本文的文献

1
Continuous glucose monitoring system in diabetes in pregnancy: a narrative review.妊娠期糖尿病的连续血糖监测系统：一篇叙述性综述。
Diabetol Metab Syndr. 2025 Aug 9;17(1):322. doi: 10.1186/s13098-025-01854-x.
2
Consensus statement on standardizing CGM evaluation metrics in Latin America: an expert approach.拉丁美洲血糖监测系统（CGM）评估指标标准化共识声明：专家方法
Diabetol Metab Syndr. 2025 Jul 21;17(1):291. doi: 10.1186/s13098-025-01851-0.
3
Minimum requirements for continuous glucose monitors: What does it mean?连续血糖监测仪的最低要求：这意味着什么？

本文引用的文献

1
The Need for Standardization of Continuous Glucose Monitoring Performance Evaluation: An Opinion by the International Federation of Clinical Chemistry and Laboratory Medicine Working Group on Continuous Glucose Monitoring.持续葡萄糖监测性能评估标准化的必要性：国际临床化学与检验医学联合会持续葡萄糖监测工作组的意见
J Diabetes Sci Technol. 2024 Nov 14:19322968241296097. doi: 10.1177/19322968241296097.
2
Criteria for Personalised Choice of a Continuous Glucose Monitoring System: An Expert Opinion.连续血糖监测系统个性化选择标准：专家意见
Diabetes Ther. 2024 Nov;15(11):2263-2278. doi: 10.1007/s13300-024-01654-y. Epub 2024 Sep 30.
3
J Diabetes Sci Technol. 2025 May 17:19322968251343645. doi: 10.1177/19322968251343645.
4
Compliance With FDA iCGM Special Controls is Dependent on Study Design and Procedures.遵守美国食品药品监督管理局（FDA）的iCGM特殊控制措施取决于研究设计和程序。
J Diabetes Sci Technol. 2025 May;19(3):850-852. doi: 10.1177/19322968251329879. Epub 2025 Apr 2.
Comparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring Systems.
比较器数据特征和连续血糖监测系统临床性能评估测试程序。
Diabetes Technol Ther. 2024 Apr;26(4):263-275. doi: 10.1089/dia.2023.0465. Epub 2024 Feb 2.
4
Shining the Spotlight on Multiple Daily Insulin Therapy: Real-World Evidence of the InPen Smart Insulin Pen.聚焦多次每日胰岛素治疗：InPen 智能胰岛素笔的真实世界证据。
Diabetes Technol Ther. 2024 Jan;26(1):33-39. doi: 10.1089/dia.2023.0365. Epub 2023 Nov 29.
5
Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for Reporting.连续血糖监测系统的临床性能评估：范围综述及报告建议。
J Diabetes Sci Technol. 2023 Nov;17(6):1506-1526. doi: 10.1177/19322968231190941. Epub 2023 Aug 20.
6
Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System.第三代14天连续血糖监测系统的准确性
Diabetes Ther. 2023 Apr;14(4):767-776. doi: 10.1007/s13300-023-01385-6. Epub 2023 Mar 6.
7
Use of Continuous Glucose Monitoring in Pump Therapy Sensor Augmented Pump or Automated Insulin Delivery in Different Age Groups (0.5 to <26 Years) With Type 1 Diabetes From 2018 to 2021: Analysis of the German/Austrian/Swiss/Luxemburg Diabetes Prospective Follow-up Database Registry.2018 年至 2021 年期间，0.5 岁至<26 岁 1 型糖尿病患者使用连续血糖监测仪进行胰岛素泵治疗（传感器增强型泵或自动胰岛素输送）：德国/奥地利/瑞士/卢森堡糖尿病前瞻性随访数据库登记分析。
J Diabetes Sci Technol. 2024 Sep;18(5):1122-1131. doi: 10.1177/19322968231156601. Epub 2023 Feb 25.
8
CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review.连续血糖监测（CGM）准确性：对比欧洲合格认证（CE）标志与美国（食品药品监督管理局，FDA）和澳大利亚（治疗用品管理局，TGA）的政府监管：一项叙述性综述。
Diabetes Obes Metab. 2023 Apr;25(4):916-939. doi: 10.1111/dom.14962. Epub 2023 Feb 5.
9
Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes.1 型糖尿病的间歇性扫描连续血糖监测。
N Engl J Med. 2022 Oct 20;387(16):1477-1487. doi: 10.1056/NEJMoa2205650. Epub 2022 Oct 5.
10
Continuous glucose monitoring overview: features and evidence.连续血糖监测概述：特点和证据。
Am J Manag Care. 2022 Jul;28(4 Suppl):S60-S68. doi: 10.37765/ajmc.2022.89206.